Corcept Therapeutics

YTD

ALL

Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CORT

Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.

CEO

Joseph K. Belanoff

CEOJoseph K. Belanoff

Employees

730

Employees730

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

1998

Founded1998

Employees

730

Employees730

CORT Key Statistics

Market cap

10.01B

Market cap10.01B

Price-Earnings ratio

265.54

Price-Earnings ratio265.54

Dividend yield

—

Dividend yield—

Average volume

1.07M

Average volume1.07M

High today

$95.74

High today$95.74

Low today

$91.92

Low today$91.92

Open price

$92.21

Open price$92.21

Volume

1.19M

Volume1.19M

52 Week high

$95.74

52 Week high$95.74

52 Week low

$28.66

52 Week low$28.66

Stock Snapshot

The current Corcept Therapeutics(CORT) stock price is $95.74, with a market capitalization of 10.01B. The stock trades at a price-to-earnings (P/E) ratio of 265.54.

During the trading session on 2026-07-10, Corcept Therapeutics(CORT) shares reached a daily high of $95.74 and a low of $91.92. At a current price of $95.74, the stock is +4.2% higher than the low and still 0.0% under the high.

Trading activity shows a volume of 1.19M, compared to an average daily volume of 1.07M.

Over the past 52 weeks, Corcept Therapeutics(CORT) stock has traded between a high of $95.74 and a low of $28.66.

CORT News

24/7 Wall St. 12h

Corcept Therapeutics : CORT - 24/7 Wall St.

...

Simply Wall St 13h

Is Corcept Therapeutics Fully Valued On Its Russell Index Removal?

Advertisement What Corcept’s Index Removal Could Mean for Investors Corcept Therapeutics (CORT) was recently removed from the Russell 1000 Growth Defensive In...

Simply Wall St 5d

Does Corcept’s Exit From Russell Defensive Indexes Reframe Its Risk Profile And Investor Base?

In late June 2026, Corcept Therapeutics was removed from both the Russell 1000 Defensive Index and the Russell 1000 Growth-Defensive Index, ending its inclusion...

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.

Novo Nordisk

Broadcom

Robinhood Markets

Palantir Technologies

Gilead Sciences

Palo Alto Networks

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.